Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Success with the Pfizer Maternal C-19 Vaccine Trial

Congratulations to Prof. Manu Vatish and the OSPREA-Gynae team on recruiting their first participant to the Pfizer maternal C-19 vaccine trial on 22nd July.

First woman in UK receives dose of therapeutic HPV vaccine

Cancer

NDWRH and Vaccitech Ltd, a clinical-stage biopharmaceutical company engaged in the discovery and development of vaccines for the treatment and prevention of infectious diseases and cancer, see the first woman in the UK receive the first dose of a novel therapeutic HPV vaccine for the HPV001 clinical trial in Oxford.

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

PhD Student of the Year Winner!

Department

In a record breaking year for the Postgrad Awards 2021, DPhil student Tolu Awoyemi wins PhD Student of the Year. The award recognises the individual PhD student who has become an excellent and inquisitive researcher, who is an integral part of their research group, someone who encourages and supports more junior members of the team, and works alongside the research community more widely.

Pfizer Maternal C-19 Vaccine Trial Launch

The Pfizer Maternal C-19 Vaccine Trial has launched at Oxford University Hospitals NHS Foundation Trust for women between 24-34 weeks pregnant. The Nuffield Department of Women’s & Reproductive Health’s team of doctors, research midwives and nurses are delivering this critical trial to evaluate the safety, tolerability, and immunogenicity of the Pfizer vaccine in pregnant women.

A way to a woman’s heart might be through her bones

Further research into the relationship between brittle bones and women's heart disease risk could be beneficial suggest Drs Dexter Canoy and Kazem Rahimi at the Nuffield Dept of Women's & Reproductive Health.

Blood pressure medication prevents cardiovascular diseases even when blood pressure is not raised

The world's most comprehensive study of 345,000 people from 48 randomised clinical trials which revealed blood pressure-lowering medication is effective in adults, regardless of starting blood pressure level, is published in The Lancet.

Research uncovers high risk to pregnant women from COVID-19

A study of more than 2,100 pregnant women across 18 countries worldwide has revealed that COVID-19 is associated with a higher risk of severe maternal and newborn complications than previously recognised.

New Endometriosis podcast launched: "Unheard of"

Department

Listen now to the first episode ‘Unheard of – The hidden voice of Endometriosis.’ A bold new podcast series co-hosted by DPhil students Danielle Perro and Magda Mareckova, it seeks answers to the biggest questions posed by the Endometriosis community.

Blood pressure lowering drugs not found to increase risk of cancer

A world leading study involving over 260,000 participants has sought to resolve the long debated issue about whether using antihypertensive medication heightens the chance of developing cancer.

Professor Cecilia Lindgren appointed Director of the Big Data Institute

Professor Cecilia Lindgren (Prof of Genomic Endocrinology & Metabolism at the Nuffield Dept of Women's & Reproductive Health) has been appointed as the new Director of the University of Oxford’s Big Data Institute.

Celebrating International Women's Day

100 years since women were admitted as full members of the University of Oxford, women now hold vital posts at all levels of this institution.

Singula Bio provides new hope for cancer with diverse, individualised therapies

Cancer

The Oxford spinout will draw on a multi-discipline approach for therapies which work with a patient to eliminate cancer.

New sequencing methods for distinguishing DNA modifications

A collaboration between Prof Ahmed's group at the Nuffield Dept of Women's & Reproductive Health and Dr Chunxiao Song’s lab at the Ludwig Institute for Cancer Research, has established new sequencing methods for distinguishing DNA modifications. The paper: "Subtraction-free and bisulfite-free specific sequencing of 5-methylcytosine and its oxidized derivatives at base resolution" has been published in Nature Communications.

Europe’s first living biobank stores reproductive cells to save animals from extinction

Nature’s SAFE, Europe’s first Living Biobank dedicated to preserving endangered animals has been launched with the mission to save animals from extinction, by harnessing regeneration and reproductive technologies developed via domestic animal breeding.

Accurate predictions of ovarian cancer outcome possible with new classification system

The new, Oxford-developed method for subtyping ovarian cancer has been validated in a recent collaboration between the University of Oxford and Imperial College London. Dubbed the ‘Oxford Classic’, researchers have demonstrated that it enables the accurate prediction of patient disease outcome, as well as the development of new targeted cancer therapies.

No limit to the benefits of exercise in reducing the risk of cardiovascular disease

A new study led by the University of Oxford on over 90,000 participants shows that there is no upper threshold to the benefits of exercise in reducing the risk of cardiovascular disease – ‘every move counts towards better cardiovascular health.

Scan academy webinars

Celebrating the successful launch of scan.academy - an initiative dedicated to improving obstetric ultrasound through state-of-the-art education.

Africa’s 35 Under 35 Award

A fantastic achievement for DPhil student Toluwalase Awoyemi from Prof Vatish's research group! He is recognised with an Africa 35.35 Award - a celebration of the top 35 leading young changemakers under 35 in Africa in 2020.

Load More